Literature DB >> 7635974

Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys.

K A Griffin1, M M Picken, A K Bidani.   

Abstract

Hypertensive mechanisms are postulated to play a major role in the progressive glomerulosclerosis (GS) after renal mass reduction. But, in contrast to converting enzyme inhibitors, BP reduction by calcium channel blockers, has not provided consistent protection. Radiotelemetric BP monitoring for 7 wk was used to compare nifedipine (N) and enalapril (E) in the rat approximately 5/6 renal ablation model. After the first week, rats received N, E, or no treatment (C). The overall averaged systolic BP in C (173 +/- 7 mmHg) was reduced by both E and N (P < 0.001), but E was more effective (113 +/- 2 vs. 134 +/- 3 mmHg, P < 0.01). GS was prevented by E (2 +/- 1 vs. 26 +/- 5% in C) but not by N (25 +/- 6%). GS correlated well with the overall averaged BP in individual animals of all groups, but the slope of the relationship was significantly steeper in N compared with C+E rats (P < 0.02), suggesting greater pressure transmission to the glomeruli and GS for any given BP. Since autoregulatory mechanisms provide the primary protection against pressure transmission, renal autoregulation was examined at 3 wk in additional rats. Autoregulation was impaired in C rats, was not additionally altered by E, but was completely abolished by N. These data demonstrate the importance of autoregulatory mechanisms in the pathogenesis of hypertensive injury and suggest that calcium channel blockers which adversely affect pressure transmission may not provide protection despite significant BP reduction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635974      PMCID: PMC185265          DOI: 10.1172/JCI118125

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Glomerular hemodynamic adaptations in remnant nephrons: effects of verapamil.

Authors:  J C Pelayo; D C Harris; P F Shanley; G J Miller; R W Schrier
Journal:  Am J Physiol       Date:  1988-03

Review 2.  Nonimmunologic mechanisms of glomerular injury.

Authors:  J L Olson; R H Heptinstall
Journal:  Lab Invest       Date:  1988-11       Impact factor: 5.662

3.  The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.

Authors:  B Jackson; C I Johnston
Journal:  J Hypertens       Date:  1988-06       Impact factor: 4.844

4.  Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II.

Authors:  P K Carmines; L G Navar
Journal:  Am J Physiol       Date:  1989-06

5.  Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis.

Authors:  Y Yoshida; A Fogo; I Ichikawa
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

6.  "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy.

Authors:  T Yoshioka; H Shiraga; Y Yoshida; A Fogo; A D Glick; W M Deen; J R Hoyer; I Ichikawa
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 7.  Hypertension and renal diseases.

Authors:  D S Baldwin; J Neugarten
Journal:  Am J Kidney Dis       Date:  1987-09       Impact factor: 8.860

8.  Verapamil protects against progression of experimental chronic renal failure.

Authors:  D C Harris; W S Hammond; T J Burke; R W Schrier
Journal:  Kidney Int       Date:  1987-01       Impact factor: 10.612

Review 9.  The progression of renal disease.

Authors:  S Klahr; G Schreiner; I Ichikawa
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

10.  Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog.

Authors:  M Pagani; F Lombardi; S Guzzetti; O Rimoldi; R Furlan; P Pizzinelli; G Sandrone; G Malfatto; S Dell'Orto; E Piccaluga
Journal:  Circ Res       Date:  1986-08       Impact factor: 17.367

View more
  37 in total

1.  Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliers.

Authors:  Karen Griffin; Aaron Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Geoffrey Williamson; Anil Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.

Authors:  Karen A Griffin; Aaron Polichnowski; Natalia Litbarg; Maria Picken; Manjeri A Venkatachalam; Anil K Bidani
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

4.  Sympathetic nerves and the progression of chronic kidney disease during 5/6 nephrectomy: studies in sympathectomized rats.

Authors:  Robert A Augustyniak; Maria M Picken; David Leonard; Xin J Zhou; Weiguo Zhang; Ronald G Victor
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-06-29       Impact factor: 2.557

5.  Increased nocturnal blood pressure variability is associated with renal arteriolar hyalinosis in normotensive patients with IgA nephropathy.

Authors:  Shinsuke Isobe; Naro Ohashi; Sayaka Ishigaki; Naoko Tsuji; Takayuki Tsuji; Akihiko Kato; Hideo Yasuda
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

6.  Postmenopausal hypertension: role of the Renin-Angiotensin system.

Authors:  Licy L Yanes; Damian G Romero; Radu Iliescu; Huimin Zhang; Deborah Davis; Jane F Reckelhoff
Journal:  Hypertension       Date:  2010-08-02       Impact factor: 10.190

Review 7.  Hypertension and atherosclerosis: clinical implications from the ALLHAT Trial.

Authors:  John B Standridge
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

Review 8.  Potential risks of calcium channel blockers in chronic kidney disease.

Authors:  Karen A Griffin; Anil K Bidani
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

Review 9.  Hypertension and chronic kidney disease progression: why the suboptimal outcomes?

Authors:  Anil K Bidani; Karen A Griffin; Murray Epstein
Journal:  Am J Med       Date:  2012-08-17       Impact factor: 4.965

10.  Blood pressure and diabetic nephropathy.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-03       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.